Emergent BioSolutions Inc. — Director's Dealing 2022

May 25, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2022-05-24

Reporting Person: Zoon Kathryn C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-24	Common Stock	S	1996	$35.53	Disposed	12381	Direct

Footnotes

F1: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.